These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5421296)

  • 1. [Nature of "LATS" immunoglobulin with prolonged thyreotropic action and localization of its antigen].
    Benhamou-Glynn N
    Ann Inst Pasteur (Paris); 1970 Apr; 118(4):539-46. PubMed ID: 5421296
    [No Abstract]   [Full Text] [Related]  

  • 2. The long-acting thyroid stimulator.
    Munro DS
    Sci Basis Med Annu Rev; 1970; ():21-30. PubMed ID: 4920180
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the interaction of long-acting thyroid stimulator (LATS) with soluble thyroid fractions.
    Amino N; Miyai K; Azukizawa M; Kumahara Y
    Acta Endocrinol (Copenh); 1971 Dec; 68(4):625-44. PubMed ID: 5171628
    [No Abstract]   [Full Text] [Related]  

  • 4. [An antibody called LATS].
    Letonturier P; Tourneur R
    Nouv Presse Med; 1975 Jan; 4(3):177-9. PubMed ID: 1079340
    [No Abstract]   [Full Text] [Related]  

  • 5. LATS and thyroid autoantibodies.
    Beall GN; Solomon DH
    Clin Exp Immunol; 1968 Sep; 3(7):615-9. PubMed ID: 4883066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity and specificity of blood and thyroid radio-iodine assays for TSH and LATS and inhibitory effect of corticosteroid.
    Sharard A
    N Z Med J; 1975 Jan; 81(531):21-2. PubMed ID: 1055309
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of various iodination procedures on the biological activity of LATS.
    Fenzi GF; Romaldini JH; Grasso L; Raccis E; Pinchera A; Baschieri L
    J Nucl Biol Med; 1972; 16(2):55-7. PubMed ID: 4662340
    [No Abstract]   [Full Text] [Related]  

  • 9. The pathogenesis of thyrotoxicosis the discovery of LATS.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):15-7. PubMed ID: 1055308
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the actions of thyroid-stimulating hormone and the long-acting thyroid stimulator in an in vitro assay.
    Brown J; Ensor J; Munro DS
    Proc R Soc Med; 1968 Jul; 61(7):652-4. PubMed ID: 5664277
    [No Abstract]   [Full Text] [Related]  

  • 11. TSH- or LATS-stimulated thyroid hormone release is inhibited by iodide.
    Ochi Y; DeGroot LJ
    Endocrinology; 1969 Jun; 84(6):1305-9. PubMed ID: 5781122
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of the thyroid-stimulating globulin (LATS) by particulate and soluble cell fractions.
    Benhamou-Glynn N; el-Kabir DJ; Doniach D; Roitt IM
    Proc R Soc Med; 1968 Dec; 61(12):1303-5. PubMed ID: 4178461
    [No Abstract]   [Full Text] [Related]  

  • 13. Isoelectric focusing of long-acting thyroid stimulator immunoglobulin G.
    Lonergan C; Babiarz D; Burke G
    J Clin Endocrinol Metab; 1973 Mar; 36(3):439-44. PubMed ID: 4631063
    [No Abstract]   [Full Text] [Related]  

  • 14. The distribution of the long-acting thyroid stimulator among gamma G-immunoglobulins.
    Smith BR; Munro DS; Dorrington KJ
    Biochim Biophys Acta; 1969 Aug; 188(1):89-100. PubMed ID: 5820688
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct evidence for human thyroidal stimulation by LATS-protector.
    Shishiba Y; Shimizu T; Yoshimura S; Shizume K
    J Clin Endocrinol Metab; 1973 Mar; 36(3):517-21. PubMed ID: 4739312
    [No Abstract]   [Full Text] [Related]  

  • 16. [Discrepancy between thyroid stimulation by LATS and inactivation by thyroid microsomes].
    Shishiba Y; Shimizu T; Yoshimura S; Shizume K
    Nihon Naibunpi Gakkai Zasshi; 1970 May; 46(2):122-6. PubMed ID: 5463390
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody nature of the long-acting thyroid stimulator.
    Földes J; Takõ J; Bãnos C; Gesztesi E
    Acta Med Acad Sci Hung; 1971; 28(3):313-9. PubMed ID: 5154552
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating inhibitor of LATS: a bioassay artefact.
    Burke G
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1244-50. PubMed ID: 4740050
    [No Abstract]   [Full Text] [Related]  

  • 19. The value of IgG separation for the detection of LATS in human serum.
    Bonnyns M; Vanhaelst L
    Clin Exp Immunol; 1969 May; 4(5):597-601. PubMed ID: 5815122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of long-acting thyroid stimulator in vivo.
    Smith BR; Munro DS
    J Endocrinol; 1972 Jan; 52(1):189-96. PubMed ID: 5061150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.